LTCHD & Extended Watchlist

mCig, Inc. LTCHD

LTCHD landed us atop the Penny Stock Rumble following yesterday morning’s alert.  After touching an early morning low of .12, the stock would stair-step its way up for the entire day, closing out the afternoon at its high of .23. That was a golden opportunity for our subscribers to bank up to 92% in gains on a single session.

This excellent daily performance came on a large amount of volume, and spawned a nice setup for the chart as the 50DMA is preparing for a Golden Cross of the 200DMA. We definitely want to keep this play on our watchlists moving forward. As is the case with any heavy gainer, we also want to stay cautious for a possible reversal.

Extended Watchlist:
CYNX, SAPX, LOTE, LOCM, ENVI, GRPN, PLUG

LTCHD, EDXC, PVEN, FB & Extended Watchlist

mCig, Inc. LTCHD

We put LTCHD up on yesterday afternoon’s Extended Watchlist, and are entering it into the discussion this morning as a new play on our marijuana-related stock radar. The company has recently transitioned to a new name, from Lifetech Industries to the current mCig. Along with that change, the company effected a 10-for-1 forward split.

For people who already owned shares prior to the restructuring, those shares were subject to a routine hold, which can take 3-5 days for the position to become free-trading. So we are on the lookout for a pullback this mid-week as that occurs, and people attempt to lock in profits by selling their shares into the market.

From there, we’ll be on the lookout for a bottom, and subsequent bounce.

The company falls under the marijuana stock category, as they are preparing for the rollout of their first mCig product within the next month. The company will be looking to capitalize on the legalization of marijuana in two states, as well as the growing popularity of “vapor pens” which vaporize cannabis concentrates for consumption.

BELLEVUE, WA, Aug 28, 2013 (Marketwired via COMTEX) — Lifetech Industries, Inc. (OTCBB: LTCHD), announces today that it has changed its name to mCig, Inc. and completed a forward stock split on a 10-for-1 basis.

On August 2, 2013, the Company’s Certificate of Incorporation was amended and restated to effect the name change and the forward stock split. The name change is part of an initiative led by incoming CEO Paul Rosenberg to reposition the company and its technology by launching a new consumer product, the mCig — a purpose built loose leaf eCig that will be launched next month.

mCig’s CEO, Paul Rosenberg, commented: “With the name change complete we can now focus on the next chapter of our business development targeting two long-term secular trends by developing consumer products that are exciting and disruptive. We will be updating our shareholders shortly with more information on our first product the mCig which will be launched in Q3 2013.”

The name change and the forward stock split were also approved by the Financial Industry Regulatory Authority (“FINRA”). The name change and forward split will be effective for trading purposes on the open of business on Thursday August 29, 2013. The new symbol will be (LTCHD) for 20 business days until September 27, 2013 when the symbol will change to (MCIG).

ENDEXX Corp. EDXC

EDXC is another medical marijuana play that we’ve been covering for quite some time. It also appeared in Friday’s report that revisited our interest in many cannabis stocks. Since that time, EDXC has traded from a low of .055 (Friday) to yesterday’s high of .097. That works out to a two-session move of 76%

Congrats to anyone who was able to take advantage of that timely alert, and be sure to check out that report containing all of our marijuana interests, as the entire sector was given a morale boost via last week’s US Department of Justice announcement that the federal government would not be interfering in individual states rights to make marijuana available to their citizens for both medical and recreational use.


Press Ventures, Inc. PVEN

PVEN has experienced an abnormal burst in volume over the past week or so, and yesterday’s volume exceeded the three days’ prior combined. Given that the stock wasn’t really trading up to that point, we have reason to suspect that PVEN could be the subject of an upcoming promotion. This out-of-the-blue volume explosion could be a result of front-loading, and so we are placing this stock on watch for any major price movements that could occur.

We also exercise the utmost caution when dealing with plays that have promotional activity going on behind the scenes, and this instance is no different.

Facebook, Inc. FB Options

FB has recently been pushing its 52-week highs (Hit 42.26 on Friday), so we are looking at how to capitalize on the trend via options trading. The 09/13 $41 Calls (closed at 1.57 yesterday) are of great interest to us, because if FB can breakout to $45 by next Friday, we could be looking at multi-bag gains from these contracts.

Extended Watchlist:
RMTI, INO, ZLCS, CYTK, STXS

Afternoon Update on Plandai Biotech (PLPL)

Plandai Biotechnology, Inc. PLPL
We’re sending out an update on PLPL this afternoon following this morning’s report. After trading as low as .55, the stock made its way back to .67, registering a 22% intraday gain in the process, and is currently holding support above the 50DMA.
In addition to an opportunity for a tidy profit during early trading, PLPL provided the public with a new press release that you can check out below. It eludes to an intellectual property licensing agreement, under the terms of which the company should be able to increase the effectiveness of its botanical extracts by a significant margin.

SEATTLE, WA, September 3, 2013 – (ACCESSWIRE) – Plandai Biotechnology, Inc. (PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has signed an exclusive agreement with North-West University in Potchefstroom, South Africa, that holds the patents and associated intellectual property associated with the entrapment of compounds in long-chain fatty acids-based nano- and micro-particles, known as Pheroid(R). Under the terms of the world license, Plandai has the exclusive right to use the Pheroid(R) technology with all Phytofare polyene-based extracts, which includes proprietary extracts of most botanical matter, for human and animal use. >>> FULL PR

Some links for those who may have missed this morning’s newsletter:
PLPL Report
PLPL Video Chart

Extended Watchlist:
RENU, IWEB, LTCHD, NOK

Plandai Biotechnology, Inc. | PLPL | Added to Watchlist

Plandai Biotechnology, Inc. PLPL

Good morning traders, we hope everyone had an enjoyable long weekend. We’re bringing a new stock into the mix this morning in the agricultural/biotechnology business. The company’s main holding consists of an 8000+ acre plantation located in Mpumalanga, South Africa (2000 acres of which are used for production of green tea), and a recent licensing and raw-material provision agreement has it aligned with Phyto Nutricare.

This partnership will facilitate the delivery of Phytofare™ branded botanical extracts and nutraceuticals to the international marketplace. Some of the highlights of the Phytofare line include:

  • Patented Formula – The products are a result of years of research into plant extracts.
  • Consist of extracts taken from LIVING plant material, setting Phytofare™ apart.
  • Improved integration into bloodstream, known as “bio-availability” (More on that below)
  • Contain Nano-Sized Particles for maximum cell permeability.
  • Unique Isomeric Properties (Isomers are particles with the same molecular properties as a given element, while having different chemical properties.)

Plandai, through Phytofare™, has a chance at making a real dent in the green tea extract market. Currently, even high-purity green tea extracts on today’s market have been tested and found to be lacking in bio-availability, that is only a small amount (≤10%) of the essential nutrients are absorbed into the system. However, in USDA tests, Phytofare extracts have demonstrated improved bio-availability levels to as much as 60-80% which obviously is a dramatic increase in potency.

This apparent leap forward in green tea extract technology should allow PLPL to make its mark on the cosmeceutical, health & wellness, as well as the food & beverage industries. After all, who among current green tea extract consumers wouldn’t want the benefit of the same products they’ve come to appreciate having exponentially increased effectiveness? For this reason, we’re anxious to include PLPL on our watchlists moving forward.

We’ve also prepared a video of the PLPL chart to point out some of the highlights:

Additionally, the good folks over at BARCHART.COM currently give PLPL a 72% Overall “Buy” Rating, Including a 100% Rating on Long-Term Indicators.

More Info @

http://www.plandaibiotech.com/

Blue Horseshoe Stocks: HUGE News in the Marijuana Industry

Medical/Legal Marijuana Sector Set to Explode

If that headline seems a little sensationalistic, that’s because something sensational has happened! Many of you will recall our continuous coverage of marijuana-related stocks beginning last year, as Washington and Colorado were getting ready to vote on becoming the first states to end more than seven decades of marijuana prohibition. The prospect of companies legally being able to cash in on what is most assuredly a multi-billion dollar industry just waiting to be unlocked, was and still is, quite exciting.

We rode several hemp stocks (which we’ll mention below) to astonishing gains, and have been continuously tracking the landscape of this burgeoning market sector ever since. Even with such progress being made in legislation, as well as a positive general shift in public opinion on the subject, we still had to temper our enthusiasm. The federal government had not yet taken an official position on the issue of whether or not it would intervene in the rights of individual states to grant their citizens access to legal marijuana. And so the nation, including several other states with legalization ambitions of their own, waited for news of their ultimate fate.

Then yesterday came… In the future, Thursday, August 29th, 2013, could very well be viewed as a turning point in the fight against marijuana prohibition. The US Department of Justice finally announced their official position: The federal government WILL NOT interfere with individual states who wish to legalize, regulate, and tax marijuana for both medical and personal recreational use. The door to a pot industry boom has just been unlocked, and left wide open.

In the wake of this historic event, we thought there would be no better time to remind our readers that this was one of the main reasons we’ve been so “high” on marijuana stocks for over a year now. It is rare to witness the birth of an entire industry, and yet it seems this baby has finally arrived! Check out the enormous list of related stocks below that have appeared in previous reports (I, II, III, IV) and be sure to keep them on your radars moving forward, as a world of possibilities (without fear of federal reprisal) has just opened up for the entire sector.

HEMP, PHOT, MJNA, CBIS, RFMK, ERBB, GRNH, MDBX, MWIP, TRTC, RIGH, EXMT, EDXC, SKTO, FSPM, NRBT, GTLA, GWPRF, HESG, PARS, SRER, SFIO, XCHC & NVLX.

We’ll also be on the lookout for new marijuana related stocks, which are likely to start sprouting up like weeds now that the federal green light has been given. More on the subject is sure to come, so stay tuned to our daily reports, and good luck out there!

Get Our FREE Daily Reports!

SUBSCRIBE